DUBLIN–(BUSINESS WIRE)–The “Global Medical Food Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This study aims to understand the role of a medical food in patients’ recovery. It provides qualitative and quantitative analyses of medical food ingredients and finished products of medical food.
North America and Europe accounted for most of the market share for both medical food ingredients and finished product medical food in 2021 due to rising physician awareness and increasing medical adherence by patients. Factors supporting market growth in these regions are the expanding geriatric population, the prevalence of chronic diseases, and policymakers’ growing emphasis on malnutrition management.
The US FDA defines medical food as “a food, which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.”
Medical food is interpreted as ‘food for special medical purposes (FSMPs)’ in several countries, including Europe, India, China, and Australia and New Zealand. In Japan, medical food is interpreted as ‘food for sick’. In Canada, medical food is governed by food for special dietary use (FSDU) and infant food regulations.
Globally, the regulatory landscape for medical food is not clearly defined, even in developed economies. As medical food is not intended to prevent or treat diseases, it is not subject to the same regulatory requirements as pharmaceutical drugs.
By ingredient, the medical food market is divided into vitamins and minerals; protein ingredients (animal and plant); nutritional lipids; prebiotics; and others (amino acids and probiotics). Of these, protein ingredients held the majority share of 64.0% (2021) in the total medical food ingredients market due to the important role they play in trauma and illness recovery.
The impact of the COVID-19 pandemic is taken into account in the analysis. The pandemic induced both positive and negative changes in the medical food market. Supply chain disruptions due to the shutting down of processing facilities and other lockdown measures affected the sale of ingredients and finished medical food.
However, the negative effects were reduced to some extent due to the growing consumer awareness and research highlighting the benefits of a medical food in patients’ recovery.
Key Features
Key Topics Covered:
1. Strategic Imperatives
2. Growth Opportunity Analysis
3. Growth Opportunity Analysis – Medical Food Ingredients
4. Growth Opportunity Analysis – Finished Product Medical Food
5. Growth Opportunity Universe
6. Next Steps
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/nj4cem
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900